| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8792781 | Journal of Cataract & Refractive Surgery | 2018 | 7 Pages |
Abstract
Used prophylactically after cataract surgery, nepafenac 0.3% was efficacious in reducing macular thickness compared with a placebo 5Â weeks postoperatively, without a difference in final visual acuity.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Patrick Frensel MD, PhD, Clézio S. MD, Nathália Teles MD, Wilson Takashi MD, PhD, Milton Ruiz MD, PhD,